Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18203
Country/Region: Kenya
Year: 2017
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $18,162,015 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Orphans and Vulnerable Children (HKID) $1,073,366
Care: TB/HIV (HVTB) $822,746
Laboratory Infrastructure (HLAB) $103,437
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,147,793
Biomedical Prevention: Injection Safety (HMIN) $20,000
Testing: HIV Testing and Counseling (HVCT) $4,177,373
Sexual Prevention: Other Sexual Prevention (HVOP) $371,050
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,036,333
Treatment: Adult Treatment (HTXS) $8,556,623
Treatment: Pediatric Treatment (PDTX) $853,294
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 356
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 486
GEND_GBV <10, Male, Physical and/or Emotional Violence 2018 392
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 541
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 1,959
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 1,584
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 3,821
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 1,582
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 422
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 10
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 5,487
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 3,645
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 3,599
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 503
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 6,023
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 3,504
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 11,595
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 56
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 4,761
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 33,342
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 11,897
GEND_GBV Number of people receiving post-GBV care 2018 45,241
GEND_GBV Unknown Age, Female, Physical and/or Emotional Violence 2018 36
HTS_TST By Key Population: FSW, Negative 2018 1,582
HTS_TST By Key Population: MSM, Negative 2018 213
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 1,710,398
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 123
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 8,853
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 15,466
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 22,240
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 78
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 5,902
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 1,703
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1,340
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 25,063
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 14,324
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 7,909
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 3,299
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 12,792
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 9,604
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 1,224
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 1,285
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 226
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 3,132
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 448
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 571
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 4,249
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 1,326
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 9,359
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 2,252
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 15,707
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 9,129
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 2,252
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 2,366
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 77,995
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 23,675
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 23,458
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 147,566
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 90,448
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 226,217
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 98,916
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 363,530
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 285,134
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 34,948
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 38,527
HTS_TST Service Delivery Point (Facility) Other PITC: Unknown Age, Female, Negative 2018 6
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 86
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 6
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 127
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 15
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 22
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 66
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 144
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 138
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 168
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 181
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 330
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 99
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 121
HTS_TST Service Delivery Point (Facility) TB: Unknown Age, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 3
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 163
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 41
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 34
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 5,720
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 4,794
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 5,459
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 5,965
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 4,616
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 6,279
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 202
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 509
HTS_TST Service Delivery Point (Facility) VMMC: <1, Negative 2018 954
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 19,287
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 4,898
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 4,999
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 18,343
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 493
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 1,250
HTS_TST Sum of Test Result disaggregates 2018 30,427
HTS_TST_POS By Key Population: FSW, Positive 2018 31
HTS_TST_POS By Key Population: MSM, Positive 2018 4
HTS_TST_POS By Test Result: Positive 2018 30,427
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 276
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 482
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 670
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 437
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 330
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 119
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 207
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 166
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 69
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 69
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 78
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 189
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 30
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 298
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 153
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 90
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 516
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 189
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 205
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 2,705
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 1,676
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 4,169
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 1,883
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 6,744
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 5,385
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 701
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 700
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 88
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 52
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 43
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 67
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 91
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 59
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 59
HTS_TST_POS Service Delivery Point (Facility) TB: Unknown Age, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 121
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 96
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 113
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 123
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 97
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 128
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 399
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 77
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 2
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 1,857
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 143
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 197
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 2,197
OVC_SERV Age/Sex: <1 2018 10
OVC_SERV Age/Sex: 1-9 2018 5,394
OVC_SERV Age/Sex: 10-14 Female 2018 3,208
OVC_SERV Age/Sex: 10-14 Male 2018 2,868
OVC_SERV Age/Sex: 15-17 Female 2018 2,091
OVC_SERV Age/Sex: 15-17 Male 2018 1,884
OVC_SERV By: Age/sex: 18-24 Female 2018 1,440
OVC_SERV By: Age/sex: Male 18-24 2018 1,795
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 18,690
OVC_SERV Program Completion: Active 2018 17,365
OVC_SERV Program Completion: Graduation 2018 1,325
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2018 890
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2018 411
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2018 300
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2018 778
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2018 420
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2018 323
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2018 957
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2018 439
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2018 323
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2018 837
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2018 452
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2018 351
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2018 174
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2018 78
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2018 57
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2018 152
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2018 82
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2018 77
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2018 2,028
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2018 937
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2018 688
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2018 1,775
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2018 960
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2018 721
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2018 973
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2018 447
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2018 329
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2018 851
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2018 460
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2018 356
OVC_SERV Sum of Age/Sex disaggregates 2018 10,051
PMTCT_ART Already on ART at beginning of current pregnancy 2018 4,118
PMTCT_ART New on ART 2018 1,208
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 5,326
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 52,339
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 5,325
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,630
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 3,402
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 44
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 249
PMTCT_STAT By Age (Numerator): 10-14 2018 89
PMTCT_STAT By Age (Numerator): 15-19 2018 9,846
PMTCT_STAT By Age (Numerator): 20-24 2018 17,258
PMTCT_STAT By Age (Numerator): 25-49 2018 25,146
PMTCT_STAT By Number of known positives: 15-19 2018 661
PMTCT_STAT By Number of known positives: 20-24 2018 1,193
PMTCT_STAT By Number of known positives: 25-49 2018 2,039
PMTCT_STAT By Number of new negative: 10-14 2018 107
PMTCT_STAT By Number of new negative: 15-19 2018 9,043
PMTCT_STAT By Number of new negative: 20-24 2018 15,720
PMTCT_STAT By Number of new negative: 25-49 2018 22,144
PMTCT_STAT By Number of new positives: 15-19 2018 193
PMTCT_STAT By Number of new positives: 20-24 2018 374
PMTCT_STAT By Number of new positives: 25-49 2018 865
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 52,339
PMTCT_STAT_den By Age (Denominator): <15-19 2018 9,846
PMTCT_STAT_den By Age (Denominator): 10-14 2018 88
PMTCT_STAT_den By Age (Denominator): 20-24 2018 17,258
PMTCT_STAT_den By Age (Denominator): 25-49 2018 25,147
PP_PREV Age/sex: 10-14 Female 2018 133
PP_PREV Age/sex: 10-14 Male 2018 119
PP_PREV Age/sex: 15-19 Female 2018 132
PP_PREV Age/sex: 15-19 Male 2018 71
PP_PREV Age/sex: 20-24 Female 2018 405
PP_PREV Age/sex: 20-24 Male 2018 73
PP_PREV Age/sex: 25-49 Female 2018 3,853
PP_PREV Age/sex: 25-49 Male 2018 1,759
PP_PREV Age/sex: 50+ Female 2018 707
PP_PREV Age/sex: 50+ Male 2018 607
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 7,859
PP_PREV Sum of Age/Sex disaggregates 2018 7,859
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 62
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 330
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 108
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 525
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,032
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,025
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 63
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 332
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 107
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 529
TB_PREV By Age/Sex (Numerator): <15, Female 2018 558
TB_PREV By Age/Sex (Numerator): <15, Male 2018 519
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 16,347
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 8,010
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 25,437
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 25,437
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 28,255
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 604
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 556
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 18,166
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 8,929
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 28,255
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 154
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 790
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 201
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,322
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,467
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,631
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 167
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 834
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 205
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,425
TX_CURR Age/Sex: <1 2018 292
TX_CURR Age/Sex: <1-9 2018 3,716
TX_CURR Age/Sex: 10-14 Female 2018 1,518
TX_CURR Age/Sex: 10-14 Male 2018 1,362
TX_CURR Age/Sex: 15-19 Female 2018 1,586
TX_CURR Age/Sex: 15-19 Male 2018 857
TX_CURR Age/Sex: 20-24 Female 2018 4,883
TX_CURR Age/Sex: 20-24 Male 2018 872
TX_CURR Age/Sex: 25-49 Female 2018 46,387
TX_CURR Age/Sex: 25-49 Male 2018 21,102
TX_CURR Age/Sex: 50+ Female 2018 8,511
TX_CURR Age/Sex: 50+ Male 2018 7,362
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 98,472
TX_CURR Sum of age/sex disaggregates 2018 2,443
TX_NEW Breastfeeding status 2018 37
TX_NEW By Age/Sex: <1 2018 220
TX_NEW By Age/Sex: 1-9 2018 482
TX_NEW By Age/Sex: 10-14 Female 2018 208
TX_NEW By Age/Sex: 10-14 Male 2018 257
TX_NEW By Age/Sex: 15-19 Female 2018 474
TX_NEW By Age/Sex: 15-19 Male 2018 254
TX_NEW By Age/Sex: 20-24 Female 2018 1,454
TX_NEW By Age/Sex: 20-24 Male 2018 258
TX_NEW By Age/Sex: 25-49 Female 2018 13,827
TX_NEW By Age/Sex: 25-49 Male 2018 6,290
TX_NEW By Age/Sex: 50+ Female 2018 2,539
TX_NEW By Age/Sex: 50+ Male 2018 2,172
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 28,435
TX_NEW Pregnancy status 2018 1,182
TX_NEW Sum of Age/Sex disaggregates 2018 27,733
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 98,081
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 87,614
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,466
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 143
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,442
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 227
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 51,135
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 3,780
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 25,439
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,982
TX_PVLS Numerator: Indication: Routine 2018 81,482
TX_PVLS Numerator: Indication: Targeted 2018 6,132
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 39
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 1,162
TX_PVLS Unknown Age, Targeted, Female 2018 2
TX_PVLS Unknown Age, Targeted, Male 2018 2
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,102
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 213
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,033
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 288
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 56,813
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 4,192
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 28,268
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 2,168
TX_PVLS_den Denominator: Indication: Routine 2018 91,219
TX_PVLS_den Denominator: Indication: Targeted 2018 6,865
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 35
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 1,181
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 547
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 550
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 17,397
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8,519
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 27,013
TX_RET Numerator by Status: Breastfeeding 2018 41
TX_RET Numerator by Status: Pregnant 2018 1,204
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 28,468
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 627
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 642
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 18,241
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8,958
TX_RET_den Denominator by Status: Breastfeeding 2018 42
TX_RET_den Denominator by Status: Pregnant 2018 1,204
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 93,805
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 407
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 15
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 44
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 125
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 223
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 709
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 854
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 7,105
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 10,095
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 14,974
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 931
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 2,857
TX_TB_den Denominator: By Screen Result: Negative 2018 75,042
TX_TB_den Denominator: By Screen Result: Positive 2018 18,763
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 18,763
VMMC_CIRC By Age: 0-60 days 2018 1,003
VMMC_CIRC By Age: 10-14 2018 19,676
VMMC_CIRC By Age: 15-19 2018 4,920
VMMC_CIRC By Age: 20-24 2018 4,920
VMMC_CIRC By Age: 25-29 2018 9,838
VMMC_CIRC By Age: 30-49 2018 8,344
VMMC_CIRC By Age: 50+ 2018 491
VMMC_CIRC By circumcision technique: Device-based VMMC 2018 1,197
VMMC_CIRC By circumcision technique: Surgical VMMC 2018 47,995
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 49,192
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 48,189
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 30,007
Cross Cutting Budget Categories and Known Amounts Total: $7,669,489
Gender: Gender Based Violence (GBV) $350,000
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Gender: Gender Equality $350,000
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Key Populations: Sex Workers $120,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Key Populations: MSM and TG $30,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Motor Vehicles: Leased $180,000
Human Resources for Health $6,287,321
Motor Vehicles: Purchased $352,168